Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GARP Expression in Acute and Chronic Coronary Syndrome
NCT07384910Not yet recruiting
- Sponsor
- UCLouvain
- Start
- Feb 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Trial (3 arms), sponsored by UCLouvain. Primary endpoint: Platelet GARP expression at 2 years. Planned start Feb 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07384910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07384910.